Vassilis Nidris

Vassilis Nidris

Auto-generated profile, based on publicly available information

Vassilis Nidris

School of Medicine, University of Crete, Voutes, Heraklion, Greece

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2026 in Nature
Verified
Journal Article
Open access
PDF file
APAntonis Pikoulas
Antonis Pikoulas
IMIoannis Morianos
Ioannis Morianos
VNVassilis Nidris
Vassilis Nidris
RHRania Hamdy
Rania Hamdy
EIEvangelia Intze
Evangelia Intze
GCGeorgios Chamilos
Georgios Chamilos
Mucormycosis is an emerging, life-threatening human infection caused by Mucorales fungi1,2,3. Metabolic disorders uniquely predispose an ever-expanding group of patients to mucormycosis through poorly understood mechanisms1,2,4,5, suggesting that uncharacterized host metabolic effectors may confer protective immunity against this infection. Here we uncover a master regulatory role of albumin in host defence against Mucorales through the modulation of fungal pathogenicity. Our initial studies identified severe hypoalb uminaemia as a prominent metabolic abnormality and an independent biomarker of poor mucormycosis outcome across three distinct cohorts of patients with mucormycosis. Notably, purified albumin selectively inhibits Mucorales growth among a range of pathogens, and albumin-deficient mice display susceptibility specifically to mucormycosis. The antifungal activity of albumin is mediated by the release of bound free fatty acids (FFAs). Albumin prevents FFA oxidation, which otherwise abolishes their antifungal properties, and sera from patients with mucormycosis display high levels of oxidized FFAs. Physiologically, albumin-bound FFAs suppress the expression of key virulence factors by inhibiting protein synthesis, the reby rendering Mucorales avirulent in vivo. Overall, we identify a host defence mechanism that directs the pathogen to suppress its pathogenicity program in response to unfavourable metabolic cues regulated by albumin. These findings have major implications for the pathogenesis and management of mucormycosis.

2 February 2026 in Nature
Verified
Journal Article
Open access
PDF file
APAntonis Pikoulas
Antonis Pikoulas
IMIoannis Morianos
Ioannis Morianos
VNVassilis Nidris
Vassilis Nidris
RHRania Hamdy
Rania Hamdy
EIEvangelia Intze
Evangelia Intze
GCGeorgios Chamilos
Georgios Chamilos

4 March 2026 in Research Square
Verified
Preprint
Open access
PDF file
GCGeorgios Chamilos
Georgios Chamilos
VNVassilis Nidris
Vassilis Nidris
IMIoannis Morianos
Ioannis Morianos
ENElectra Nenedaki
Electra Nenedaki
SGSamuel Gonçalves
Samuel Gonçalves
ACAgostinho Carvalho
Agostinho Carvalho
Alveolar macrophages (AMs) employ specialized immunometabolic programs to counteract virulence mechanisms of airborne pathogens and confer host protection1. Mucormycosis is a life-threatening respiratory fungal infection that predominantly affects patients with metabolic abnormalities, especially diabetic ketoacidosis (DKA) 2, through poorly defined mechanisms. Unlike other fungi, Mucorales induce phagosome maturation arrest in AMs through persistent surface expression of melanin3,4, yet the host defense mechanisms that restrict fungal growth remain uncharacterized. Herein, we found that phagocytosis of Mucorales spores triggers the selective recruitment of Lipid Droplets (LDs) to the phagosome, through metabolic reprograming of AM metabolism toward oxidative phosphorylation (OXPHOS). Ca2+ sequestration by fungal melanin triggers this immunometabolic response in AMs by modulating mitochondria dynamics. LD targeting results in robust accumulation of host free fatty acids (FFAs) within intracellular Mucorales spores, leading to rapid mitochondrial fragmentation, suppression of aerobic glycolysis and fungal growth arrest. In DKA, nuclear stabilization of HIF1 inhibits mitochondrial function and OXPHOS-dependent LD targeting to the phagosome to promote fungal disease. Pharmacological inhibition or conditional deletion of HIF1 in AMs restores OXPHOS and protects against mucormycosis. Collectively, our findings define a melanin-driven immunometabolic defense program and reveal host and fungal metabolic vulnerabilities with important implications in pathogenesis and treatment of mucormycosis.